IL263882B1 - שתלים רפואיים ביו–מרוכבים מחוזקים בסיבים ובעלי תכולת מינרלים גבוהה - Google Patents
שתלים רפואיים ביו–מרוכבים מחוזקים בסיבים ובעלי תכולת מינרלים גבוההInfo
- Publication number
- IL263882B1 IL263882B1 IL263882A IL26388218A IL263882B1 IL 263882 B1 IL263882 B1 IL 263882B1 IL 263882 A IL263882 A IL 263882A IL 26388218 A IL26388218 A IL 26388218A IL 263882 B1 IL263882 B1 IL 263882B1
- Authority
- IL
- Israel
- Prior art keywords
- implant
- fiber
- fibers
- polymer
- mol
- Prior art date
Links
- 239000007943 implant Substances 0.000 title claims description 364
- 239000000835 fiber Substances 0.000 title claims description 266
- 239000011173 biocomposite Substances 0.000 title claims description 78
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims description 73
- 239000011707 mineral Substances 0.000 title claims description 73
- 229920000642 polymer Polymers 0.000 claims description 176
- 210000000988 bone and bone Anatomy 0.000 claims description 94
- 239000000203 mixture Substances 0.000 claims description 87
- 239000011159 matrix material Substances 0.000 claims description 72
- 238000006731 degradation reaction Methods 0.000 claims description 62
- 230000015556 catabolic process Effects 0.000 claims description 58
- 239000002557 mineral fiber Substances 0.000 claims description 47
- 239000012783 reinforcing fiber Substances 0.000 claims description 44
- 230000002787 reinforcement Effects 0.000 claims description 39
- 230000003014 reinforcing effect Effects 0.000 claims description 38
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 31
- 238000004519 manufacturing process Methods 0.000 claims description 24
- 238000002513 implantation Methods 0.000 claims description 23
- 239000000377 silicon dioxide Substances 0.000 claims description 15
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 14
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 claims description 12
- 229910052681 coesite Inorganic materials 0.000 claims description 12
- 229910052906 cristobalite Inorganic materials 0.000 claims description 12
- 229910052682 stishovite Inorganic materials 0.000 claims description 12
- 229910052905 tridymite Inorganic materials 0.000 claims description 12
- 235000012239 silicon dioxide Nutrition 0.000 claims description 11
- 229920001610 polycaprolactone Polymers 0.000 claims description 10
- 239000004632 polycaprolactone Substances 0.000 claims description 8
- 230000014759 maintenance of location Effects 0.000 claims description 7
- 239000000178 monomer Substances 0.000 claims description 7
- 229920001244 Poly(D,L-lactide) Polymers 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 4
- 210000002435 tendon Anatomy 0.000 claims description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 3
- 229920002643 polyglutamic acid Polymers 0.000 claims description 3
- 239000002131 composite material Substances 0.000 description 104
- 239000000463 material Substances 0.000 description 74
- 229920001577 copolymer Polymers 0.000 description 29
- 238000012360 testing method Methods 0.000 description 28
- 210000001519 tissue Anatomy 0.000 description 25
- 239000000945 filler Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 20
- 230000000399 orthopedic effect Effects 0.000 description 20
- 239000012890 simulated body fluid Substances 0.000 description 18
- 206010017076 Fracture Diseases 0.000 description 17
- 229920002988 biodegradable polymer Polymers 0.000 description 16
- 239000004621 biodegradable polymer Substances 0.000 description 16
- 230000007423 decrease Effects 0.000 description 16
- 239000003733 fiber-reinforced composite Substances 0.000 description 16
- 229920001432 poly(L-lactide) Polymers 0.000 description 16
- 239000003365 glass fiber Substances 0.000 description 14
- 229920000747 poly(lactic acid) Polymers 0.000 description 14
- 208000010392 Bone Fractures Diseases 0.000 description 13
- 238000000338 in vitro Methods 0.000 description 12
- 239000004626 polylactic acid Substances 0.000 description 12
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 11
- 239000011521 glass Substances 0.000 description 11
- 230000004580 weight loss Effects 0.000 description 11
- 238000011534 incubation Methods 0.000 description 10
- 238000000748 compression moulding Methods 0.000 description 9
- 230000001054 cortical effect Effects 0.000 description 9
- 238000013461 design Methods 0.000 description 9
- 239000004633 polyglycolic acid Substances 0.000 description 9
- 229950008885 polyglycolic acid Drugs 0.000 description 9
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 9
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 8
- 239000002952 polymeric resin Substances 0.000 description 8
- 239000012763 reinforcing filler Substances 0.000 description 8
- 238000007655 standard test method Methods 0.000 description 8
- 229920001897 terpolymer Polymers 0.000 description 8
- 238000005452 bending Methods 0.000 description 7
- 229920006237 degradable polymer Polymers 0.000 description 7
- 230000035876 healing Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 238000005297 material degradation process Methods 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 239000002861 polymer material Substances 0.000 description 7
- -1 polytetrafluoroethylene Polymers 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- RBMHUYBJIYNRLY-UHFFFAOYSA-N 2-[(1-carboxy-1-hydroxyethyl)-hydroxyphosphoryl]-2-hydroxypropanoic acid Chemical compound OC(=O)C(O)(C)P(O)(=O)C(C)(O)C(O)=O RBMHUYBJIYNRLY-UHFFFAOYSA-N 0.000 description 6
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000000278 osteoconductive effect Effects 0.000 description 6
- 238000013001 point bending Methods 0.000 description 6
- 229920001434 poly(D-lactide) Polymers 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 229920002635 polyurethane Polymers 0.000 description 5
- 239000004814 polyurethane Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000003252 repetitive effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 229920003002 synthetic resin Polymers 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 4
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 239000001506 calcium phosphate Substances 0.000 description 4
- 239000007857 degradation product Substances 0.000 description 4
- 239000011152 fibreglass Substances 0.000 description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
- 238000001746 injection moulding Methods 0.000 description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 239000011208 reinforced composite material Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 230000002459 sustained effect Effects 0.000 description 4
- 238000009864 tensile test Methods 0.000 description 4
- 229920001661 Chitosan Polymers 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229920001710 Polyorthoester Polymers 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000005312 bioglass Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000007822 coupling agent Substances 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000009969 flowable effect Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 239000011810 insulating material Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 238000003754 machining Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 229920000117 poly(dioxanone) Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000002990 reinforced plastic Substances 0.000 description 3
- 238000007634 remodeling Methods 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 238000004544 sputter deposition Methods 0.000 description 3
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 3
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 3
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 2
- 229920001651 Cyanoacrylate Polymers 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 238000012668 chain scission Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 229910052593 corundum Inorganic materials 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000023753 dehiscence Effects 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000002138 osteoinductive effect Effects 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 2
- 238000012667 polymer degradation Methods 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229910001845 yogo sapphire Inorganic materials 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- VKSWWACDZPRJAP-UHFFFAOYSA-N 1,3-dioxepan-2-one Chemical compound O=C1OCCCCO1 VKSWWACDZPRJAP-UHFFFAOYSA-N 0.000 description 1
- VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 1
- SJDLIJNQXLJBBE-UHFFFAOYSA-N 1,4-dioxepan-2-one Chemical compound O=C1COCCCO1 SJDLIJNQXLJBBE-UHFFFAOYSA-N 0.000 description 1
- AOLNDUQWRUPYGE-UHFFFAOYSA-N 1,4-dioxepan-5-one Chemical compound O=C1CCOCCO1 AOLNDUQWRUPYGE-UHFFFAOYSA-N 0.000 description 1
- ALRHLSYJTWAHJZ-UHFFFAOYSA-M 3-hydroxypropionate Chemical compound OCCC([O-])=O ALRHLSYJTWAHJZ-UHFFFAOYSA-M 0.000 description 1
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 description 1
- 238000010146 3D printing Methods 0.000 description 1
- 208000027502 Ankle fracture Diseases 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 208000024779 Comminuted Fractures Diseases 0.000 description 1
- 229920002430 Fibre-reinforced plastic Polymers 0.000 description 1
- 206010023215 Joint effusion Diseases 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010073853 Osteochondral fracture Diseases 0.000 description 1
- 206010069135 Periprosthetic fracture Diseases 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920010741 Ultra High Molecular Weight Polyethylene (UHMWPE) Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000003339 best practice Methods 0.000 description 1
- 239000005313 bioactive glass Substances 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000011151 fibre-reinforced plastic Substances 0.000 description 1
- 238000009730 filament winding Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 238000011540 hip replacement Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000013150 knee replacement Methods 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002113 nanodiamond Substances 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000196 viscometry Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/80—Cortical plates, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L31/128—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing other specific inorganic fillers not covered by A61L31/126 or A61L31/127
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C70/00—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
- B29C70/04—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts comprising reinforcements only, e.g. self-reinforcing plastics
- B29C70/06—Fibrous reinforcements only
- B29C70/10—Fibrous reinforcements only characterised by the structure of fibrous reinforcements, e.g. hollow fibres
- B29C70/16—Fibrous reinforcements only characterised by the structure of fibrous reinforcements, e.g. hollow fibres using fibres of substantial or continuous length
- B29C70/22—Fibrous reinforcements only characterised by the structure of fibrous reinforcements, e.g. hollow fibres using fibres of substantial or continuous length oriented in at least two directions forming a two dimensional structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/84—Fasteners therefor or fasteners being internal fixation devices
- A61B17/86—Pins or screws or threaded wires; nuts therefor
- A61B17/866—Material or manufacture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2/2846—Support means for bone substitute or for bone graft implants, e.g. membranes or plates for covering bone defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30069—Properties of materials and coating materials elastomeric
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Composite Materials (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Cardiology (AREA)
- Textile Engineering (AREA)
- Mechanical Engineering (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662354823P | 2016-06-27 | 2016-06-27 | |
| PCT/IL2017/050707 WO2018002917A1 (en) | 2016-06-27 | 2017-06-26 | Fiber reinforced biocomposite medical implants with high mineral content |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL263882A IL263882A (he) | 2019-01-31 |
| IL263882B1 true IL263882B1 (he) | 2024-04-01 |
| IL263882B2 IL263882B2 (he) | 2024-08-01 |
Family
ID=60786965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL263882A IL263882B2 (he) | 2016-06-27 | 2017-06-26 | שתלים רפואיים ביו–מרוכבים מחוזקים בסיבים ובעלי תכולת מינרלים גבוהה |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11491264B2 (he) |
| EP (1) | EP3474913B1 (he) |
| JP (1) | JP2019518568A (he) |
| KR (1) | KR102456201B1 (he) |
| CN (1) | CN109641081A (he) |
| AU (1) | AU2017287968B2 (he) |
| CA (1) | CA3028635A1 (he) |
| FI (1) | FI3474913T3 (he) |
| IL (1) | IL263882B2 (he) |
| SG (2) | SG11201811090WA (he) |
| WO (1) | WO2018002917A1 (he) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11484627B2 (en) | 2010-10-20 | 2022-11-01 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
| US20120101593A1 (en) | 2010-10-20 | 2012-04-26 | BIOS2 Medical, Inc. | Implantable polymer for bone and vascular lesions |
| WO2015095745A1 (en) | 2010-10-20 | 2015-06-25 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
| US11058796B2 (en) | 2010-10-20 | 2021-07-13 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
| US11291483B2 (en) | 2010-10-20 | 2022-04-05 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants |
| US10525169B2 (en) | 2010-10-20 | 2020-01-07 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
| US11207109B2 (en) | 2010-10-20 | 2021-12-28 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
| EP2819620A4 (en) | 2012-02-29 | 2015-11-04 | 206 Ortho Inc | METHOD AND APPARATUS FOR TREATING BONE FRACTURES, INCLUDING THE USE OF COMPOSITE IMPLANTS |
| AU2014268380B2 (en) | 2013-05-23 | 2019-06-27 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants |
| BR112017001049B1 (pt) | 2014-09-07 | 2022-05-10 | Ossio Ltd | Implante ortopédico compreendendo um material estrutural absorvível |
| CN107106210B (zh) | 2014-12-26 | 2021-05-04 | 奥西奥有限公司 | 连续纤维增强的生物复合材料医用植入物 |
| FI3474913T3 (fi) | 2016-06-27 | 2024-07-29 | Ossio Ltd | Kuitulujitettuja lääketieteellisiä biokomposiitti-implantteja, joilla on korkea mineraalipitoisuus |
| US11540866B2 (en) * | 2017-03-29 | 2023-01-03 | Bone Solutions, Inc. | Implant of osteostimulative material |
| US10722280B2 (en) * | 2017-03-29 | 2020-07-28 | Bone Solutions, Inc. | Implant of osteostimulative material |
| CN111110404B (zh) * | 2020-01-10 | 2021-04-23 | 苏州诺普再生医学有限公司 | 一种3d打印的多结构骨复合支架 |
| GB2597063A (en) * | 2020-07-09 | 2022-01-19 | Invibio Device Component Mfg Limited | Composite materials |
| CN112370634B (zh) * | 2020-11-03 | 2023-04-25 | 山东华安生物科技有限公司 | 一种复合管及其制备方法和应用 |
| IL294542A (he) | 2021-07-19 | 2023-02-01 | Ossio Ltd | מכשיר עם צינורית להחדרת שתלים בעל עומק החדרה מתכוונן |
| IL314736A (he) * | 2022-02-16 | 2024-10-01 | Purac Biochem B V | חומר מרוכב מתאים ביולוגית וניתן לספיגה מחדש ושיטה לקבלתו |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100121463A1 (en) * | 2005-04-27 | 2010-05-13 | Bioretec Oy | Bioabsorbable and bioactive composite material and a method for manufacturing the composite |
| US20120040015A1 (en) * | 2009-04-23 | 2012-02-16 | Timo Lehtonen | Biocompatible composite and its use |
| US20120040002A1 (en) * | 2009-04-23 | 2012-02-16 | Timo Lehtonen | Resorbable and biocompatible fibre glass compositions and their uses |
| WO2016035088A1 (en) * | 2014-09-07 | 2016-03-10 | Resorbium Ltd. | Anisotropic biocomposite material, medical implants comprising same and methods of treatment thereof |
| WO2016103049A1 (en) * | 2014-12-26 | 2016-06-30 | Resorbium Ltd | Continuous-fiber reinforced biocomposite medical implants |
Family Cites Families (96)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4750905A (en) | 1985-07-10 | 1988-06-14 | Harrington Arthritis Research Center | Beam construction and method |
| US4978360A (en) | 1986-03-03 | 1990-12-18 | Zimmer, Inc. | Method of manufacturing a composite implant prosthesis |
| US5192330A (en) | 1987-01-20 | 1993-03-09 | Smith & Nephew Richards, Inc. | Orthopedic device of biocompatible polymer with oriented fiber reinforcement |
| US5064439A (en) | 1987-01-20 | 1991-11-12 | Richards Medical Company | Orthopedic device of biocompatible polymer with oriented fiber reinforcement |
| DE3734108A1 (de) | 1987-10-06 | 1989-04-20 | Mecron Med Prod Gmbh | Marknagel fuer die behandlung von knochenbruechen |
| US4911718A (en) | 1988-06-10 | 1990-03-27 | University Of Medicine & Dentistry Of N.J. | Functional and biocompatible intervertebral disc spacer |
| DE3831657A1 (de) | 1988-09-17 | 1990-03-22 | Boehringer Ingelheim Kg | Vorrichtung zur osteosynthese und verfahren zu ihrer herstellung |
| US6171338B1 (en) | 1988-11-10 | 2001-01-09 | Biocon, Oy | Biodegradable surgical implants and devices |
| US5209888A (en) | 1988-12-16 | 1993-05-11 | Fukuvi Chemical Industry Co., Ltd. | Method for producing frp screw-like fastening elements |
| US5522817A (en) | 1989-03-31 | 1996-06-04 | United States Surgical Corporation | Absorbable surgical fastener with bone penetrating elements |
| EP0442256B1 (de) | 1990-02-14 | 1996-05-29 | MAN Ceramics GmbH | Knochenimplantat |
| US5181930A (en) | 1991-04-10 | 1993-01-26 | Pfizer Hospital Products Group, Inc. | Composite orthopedic implant |
| US5312669A (en) | 1992-01-03 | 1994-05-17 | Becker Orthopedic Appliance Company | Thermoplastic composite reinforcement and method for orthotic, prosthetic and other devices |
| FR2709949B1 (fr) | 1993-09-14 | 1995-10-13 | Commissariat Energie Atomique | Prothèse de disque intervertébral. |
| US5522904A (en) | 1993-10-13 | 1996-06-04 | Hercules Incorporated | Composite femoral implant having increased neck strength |
| US5507814A (en) | 1994-03-30 | 1996-04-16 | Northwestern University | Orthopedic implant with self-reinforced mantle |
| AU3635095A (en) * | 1994-09-20 | 1996-04-09 | Smith & Nephew Richards Inc. | Composite threaded component and method of manufacture |
| AU715915B2 (en) | 1995-09-14 | 2000-02-10 | Takiron Co. Ltd. | Osteosynthetic material, composited implant material, and process for preparing the same |
| US6299649B1 (en) | 1996-06-22 | 2001-10-09 | Fu-Kuo Chang | Unbalanced prosthetic device for providing side-dependent twisting-rotational axial-loading coupling |
| US6602293B1 (en) | 1996-11-01 | 2003-08-05 | The Johns Hopkins University | Polymeric composite orthopedic implant |
| US5728098A (en) | 1996-11-07 | 1998-03-17 | Sdgi Holdings, Inc. | Multi-angle bone screw assembly using shape-memory technology |
| US6004650A (en) | 1996-12-31 | 1999-12-21 | Owens Corning Fiberglas Technology, Inc. | Fiber reinforced composite part and method of making same |
| DE69840171D1 (de) | 1997-05-30 | 2008-12-11 | Osteobiologics Inc | Faserverstärkte,poröse,biologisch abbaubare implantatvorrichtung |
| US7541049B1 (en) | 1997-09-02 | 2009-06-02 | Linvatec Biomaterials Oy | Bioactive and biodegradable composites of polymers and ceramics or glasses and method to manufacture such composites |
| CN1089009C (zh) | 1997-10-22 | 2002-08-14 | 刘建宇 | 高分子人体植入物及其制备方法产品和用途 |
| DE19823737C2 (de) | 1998-05-27 | 2003-05-15 | Sepitec Foundation Vaduz | Verbundwerkstoff aus Polymer- oder Keramikmaterialien |
| US6200321B1 (en) | 1998-09-10 | 2001-03-13 | Hand Innovations, Inc. | Fracture fixation system |
| US6352667B1 (en) * | 1999-08-24 | 2002-03-05 | Absorbable Polymer Technologies, Inc. | Method of making biodegradable polymeric implants |
| AU3639301A (en) | 1999-11-01 | 2001-05-14 | Osteobiologics, Inc. | Biodegradable polymer/ceramic implant material with bimodal degradation profile |
| US7947069B2 (en) | 1999-11-24 | 2011-05-24 | University Of Washington | Medical devices comprising small fiber biomaterials, and methods of use |
| US6306140B1 (en) | 2001-01-17 | 2001-10-23 | Synthes (Usa) | Bone screw |
| CN1174716C (zh) | 2001-02-28 | 2004-11-10 | 上海市黄浦区中心医院 | 外覆生物膜的多层结构人工韧带 |
| KR100439871B1 (ko) * | 2001-04-28 | 2004-07-12 | 주식회사 메타바이오메드 | 나노섬유로 강화된 의료기구용 복합재료 및 그의 제조방법 |
| US6471707B1 (en) | 2001-05-11 | 2002-10-29 | Biomet | Bone screw having bioresorbable proximal shaft portion |
| US6916321B2 (en) | 2001-09-28 | 2005-07-12 | Ethicon, Inc. | Self-tapping resorbable two-piece bone screw |
| US6921402B2 (en) | 2001-12-27 | 2005-07-26 | Ethicon, Inc. | Polymer-based orthopedic screw and driver system with increased insertion torque tolerance and associated method for making and using same |
| AU2003217285A1 (en) | 2002-02-25 | 2003-09-09 | Graphion Technologies Usa, Llc | Expandable fastener with compressive grips |
| US8580291B2 (en) | 2002-03-15 | 2013-11-12 | The Trustees Of The University Of Pennsylvania | Fibrous composite for tissue engineering |
| SE523288C2 (sv) | 2002-07-19 | 2004-04-06 | Astra Tech Ab | Ett implantat och ett förfarande för behandling av en implantatyta |
| JP2004160157A (ja) | 2002-09-24 | 2004-06-10 | Unitika Ltd | 骨修復材料およびその製造方法 |
| GB0302026D0 (en) | 2003-01-29 | 2003-02-26 | Biocomposites Ltd | Bioabsorbable implant |
| CN1565396A (zh) | 2003-06-09 | 2005-01-19 | 上海上材生物材料有限公司 | 一种人工椎体 |
| JP2007500583A (ja) | 2003-06-13 | 2007-01-18 | タイコ・ヘルスケア・グループ・リミテッド・パートナーシップ | 外科用器具のための複数部材相互接続および吸収性ねじファスナー |
| US7153325B2 (en) | 2003-08-01 | 2006-12-26 | Ultra-Kinetics, Inc. | Prosthetic intervertebral disc and methods for using the same |
| WO2005036971A1 (en) | 2003-10-16 | 2005-04-28 | Techcom Group, Llc | Reduced digestible carbohydrate food having reduced blood glucose response |
| CN101420991A (zh) | 2003-11-20 | 2009-04-29 | 血管技术国际股份公司 | 聚合物组合物及其使用方法 |
| EP1537839A1 (en) | 2003-12-02 | 2005-06-08 | Dr. h. c. Robert Mathys Foundation | Prosthetic device for cartilage repair |
| EP1729674A4 (en) | 2004-02-05 | 2011-01-26 | Osteobiologics Inc | ABSORBABLE ORTHOPEDIC IMPLANTS |
| CN1953719B (zh) | 2004-04-26 | 2011-01-26 | 好梅迪卡整形器械公司 | 用于无血管半月板修复和再生的支架 |
| CN1299654C (zh) | 2004-06-24 | 2007-02-14 | 上海交通大学 | 全髋股骨头假体 |
| US8702716B1 (en) | 2009-09-21 | 2014-04-22 | Reva Medical Inc. | Devices, compositions and methods for bone and tissue augmentation |
| DE602005020642D1 (de) | 2004-08-13 | 2010-05-27 | Setagon Inc | Herstellungsverfahren für medizinprodukte mit nanoporösen schichten |
| US20060095134A1 (en) | 2004-10-28 | 2006-05-04 | Sdgi Holdings, Inc. | Materials, devices and methods for implantation of transformable implants |
| JP2008521560A (ja) | 2004-11-30 | 2008-06-26 | オステオバイオロジクス・インコーポレーテッド | 関節面の欠損を治療するためのインプラント及びそのデリバリーシステム |
| US8535722B2 (en) | 2005-03-16 | 2013-09-17 | North Carolina State University | Functionally graded biocompatible coating and coated implant |
| US8992622B2 (en) | 2005-05-06 | 2015-03-31 | Titan Spine, Llc | Interbody spinal implant having a roughened surface topography |
| US20070150059A1 (en) | 2005-12-22 | 2007-06-28 | Depuy Spine, Inc. | Methods and devices for intervertebral augmentation using injectable formulations and enclosures |
| US20070270969A1 (en) | 2006-05-17 | 2007-11-22 | Schmid Steven R | Welded-woven materials |
| FI124017B (fi) | 2006-06-30 | 2014-01-31 | Stick Tech Oy | Kovettavat kuitulujitetut komposiitit ja menetelmä aplikaatio-orientuneiden kuitulujitettujen komposiittien valmistamiseksi |
| WO2008095052A2 (en) | 2007-01-30 | 2008-08-07 | Loma Vista Medical, Inc., | Biological navigation device |
| FI20075246A0 (fi) | 2007-04-12 | 2007-04-12 | Bioretec Oy | Lääketieteellinen väline |
| DE102007020951A1 (de) | 2007-05-04 | 2008-11-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren und Vorrichtung zur Reinigung eines resorbierbaren Polyesters |
| JP2010529091A (ja) | 2007-06-06 | 2010-08-26 | インノテーレ・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 水硬性セメントをベースとするインプラント材料ならびにその使用 |
| FR2918081B1 (fr) | 2007-06-27 | 2009-09-18 | Cabinet Hecke Sa | Procede d'impregnation de fibres continues par une matrice polymerique composite renfermant un polymere thermoplastique |
| JP5179124B2 (ja) | 2007-09-06 | 2013-04-10 | 矢橋工業株式会社 | 骨再生誘導膜、およびその製造方法 |
| US7998499B2 (en) | 2007-10-25 | 2011-08-16 | Collagen Matrix, Inc. | Calcium-containing bone implants |
| CA2718718A1 (en) | 2008-03-21 | 2009-09-24 | Biomimedica, Inc | Methods, devices and compositions for adhering hydrated polymer implants to bone |
| CA2728686C (en) | 2008-07-04 | 2016-04-19 | Dr. H. C. Robert Mathys Stiftung | Implant device |
| BRPI0912470B8 (pt) | 2008-08-11 | 2021-06-22 | Fibralign Corp | método de produção de material de biopolímero fibrilar orientado |
| US20100168798A1 (en) | 2008-12-30 | 2010-07-01 | Clineff Theodore D | Bioactive composites of polymer and glass and method for making same |
| US9456890B2 (en) | 2009-01-15 | 2016-10-04 | The Curators Of The University Of Missouri | Scaffold for bone and tissue repair in mammals |
| EP2389124B1 (en) | 2009-01-16 | 2016-01-06 | Carbofix Orthopedics Ltd. | Composite material bone implant |
| FI20095084A0 (fi) | 2009-01-30 | 2009-01-30 | Pekka Vallittu | Komposiitti ja sen käyttö |
| WO2010128039A1 (en) | 2009-05-07 | 2010-11-11 | Dsm Ip Assets B.V. | Biodegradable composite comprising a biodegradable polymer and a glass fiber |
| US20110098826A1 (en) | 2009-10-28 | 2011-04-28 | The Trustees Of The University Of Pennsylvania | Disc-Like Angle-Ply Structures for Intervertebral Disc Tissue Engineering and Replacement |
| US10154867B2 (en) * | 2010-06-07 | 2018-12-18 | Carbofix In Orthopedics Llc | Multi-layer composite material bone screw |
| US20120040137A1 (en) | 2010-07-27 | 2012-02-16 | Arsenal Medical | Fiber composite structure |
| CN101942709B (zh) | 2010-09-26 | 2012-01-04 | 东华大学 | 一种含多壁碳纳米管的cs/pva 复合纳米纤维及其制备方法 |
| US9186302B2 (en) * | 2010-10-29 | 2015-11-17 | Curators Of The University Of Missouri | Biomaterial compositions |
| TWI494076B (zh) | 2011-04-18 | 2015-08-01 | Univ Nat Central | 醫療用鑽頭 |
| JP6055962B2 (ja) | 2011-07-13 | 2017-01-11 | キャサリン キャドレル | 骨肉インプラント合成部材およびその製造方法 |
| WO2013116624A1 (en) | 2012-02-03 | 2013-08-08 | The Trustees Of The University Of Pennsylvania | Aligned fibrous materials with spatially varying fiber orientation and related methods |
| US9090029B2 (en) | 2012-02-06 | 2015-07-28 | Warsaw Orthopedic, Inc. | Pultrusion process for preparing composites having low percentage of fibers and articles made from same |
| BR112014019797B1 (pt) * | 2012-02-10 | 2019-11-19 | Synthes Gmbh | materiais de implante porosos e métodos relacionados |
| US9005286B2 (en) | 2012-02-21 | 2015-04-14 | Thierry Giorno | PLGA/HA hydroxyapatite composite bone grafts and method of making |
| US8735504B2 (en) * | 2012-05-02 | 2014-05-27 | Warsaw Orthopedic, Inc. | Methods for preparing polymers having low residual monomer content |
| US20130317555A1 (en) | 2012-05-22 | 2013-11-28 | Benvenue Medical, Inc. | Implant and system for bone repair |
| ES2582610T3 (es) | 2012-11-09 | 2016-09-14 | Karl Leibinger Medizintechnik Gmbh & Co. Kg | Implante óseo de al menos dos materiales distintos reabsorbibles y biodegradables que pueden combinarse como material híbrido o compuesto |
| JP6415040B2 (ja) | 2013-11-29 | 2018-10-31 | キヤノン株式会社 | 画像処理装置、画像処理方法、及びプログラム |
| US9179541B1 (en) | 2014-07-10 | 2015-11-03 | International Business Machines Corporation | Surface-mount connector structure for embedded optical and electrical traces |
| US10617458B2 (en) | 2015-12-23 | 2020-04-14 | Carbofix In Orthopedics Llc | Multi-layer composite material bone screw |
| CN109219454A (zh) | 2016-03-07 | 2019-01-15 | 奥西西奥有限公司 | 表面处理的生物复合材料、包含其的医疗植入物及其治疗方法 |
| FI3474913T3 (fi) | 2016-06-27 | 2024-07-29 | Ossio Ltd | Kuitulujitettuja lääketieteellisiä biokomposiitti-implantteja, joilla on korkea mineraalipitoisuus |
| EP3320877B1 (de) | 2016-11-14 | 2021-05-26 | Andreas Schwitalla | Implantat aus faserverstärktem kunststoff |
| US20210299332A1 (en) * | 2018-03-06 | 2021-09-30 | Dsm Ip Assets B.V. | Osteoconductive fibers, medical implant comprising such osteoconductive fibers, and methods of making |
| US11896736B2 (en) * | 2020-07-13 | 2024-02-13 | Globus Medical, Inc | Biomaterial implants and methods of making the same |
-
2017
- 2017-06-26 FI FIEP17819487.4T patent/FI3474913T3/fi active
- 2017-06-26 IL IL263882A patent/IL263882B2/he unknown
- 2017-06-26 KR KR1020197001863A patent/KR102456201B1/ko active IP Right Grant
- 2017-06-26 CA CA3028635A patent/CA3028635A1/en active Pending
- 2017-06-26 US US16/311,784 patent/US11491264B2/en active Active
- 2017-06-26 CN CN201780053086.6A patent/CN109641081A/zh active Pending
- 2017-06-26 EP EP17819487.4A patent/EP3474913B1/en active Active
- 2017-06-26 SG SG11201811090WA patent/SG11201811090WA/en unknown
- 2017-06-26 JP JP2018567587A patent/JP2019518568A/ja active Pending
- 2017-06-26 WO PCT/IL2017/050707 patent/WO2018002917A1/en unknown
- 2017-06-26 AU AU2017287968A patent/AU2017287968B2/en active Active
- 2017-06-27 SG SG10201913457VA patent/SG10201913457VA/en unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100121463A1 (en) * | 2005-04-27 | 2010-05-13 | Bioretec Oy | Bioabsorbable and bioactive composite material and a method for manufacturing the composite |
| US20120040015A1 (en) * | 2009-04-23 | 2012-02-16 | Timo Lehtonen | Biocompatible composite and its use |
| US20120040002A1 (en) * | 2009-04-23 | 2012-02-16 | Timo Lehtonen | Resorbable and biocompatible fibre glass compositions and their uses |
| WO2016035088A1 (en) * | 2014-09-07 | 2016-03-10 | Resorbium Ltd. | Anisotropic biocomposite material, medical implants comprising same and methods of treatment thereof |
| WO2016103049A1 (en) * | 2014-12-26 | 2016-06-30 | Resorbium Ltd | Continuous-fiber reinforced biocomposite medical implants |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190023079A (ko) | 2019-03-07 |
| SG11201811090WA (en) | 2019-01-30 |
| SG10201913457VA (en) | 2020-03-30 |
| WO2018002917A1 (en) | 2018-01-04 |
| EP3474913A4 (en) | 2020-03-04 |
| CA3028635A1 (en) | 2018-01-04 |
| US20190282736A1 (en) | 2019-09-19 |
| IL263882B2 (he) | 2024-08-01 |
| IL263882A (he) | 2019-01-31 |
| EP3474913B1 (en) | 2024-05-08 |
| CN109641081A (zh) | 2019-04-16 |
| EP3474913A1 (en) | 2019-05-01 |
| JP2019518568A (ja) | 2019-07-04 |
| US11491264B2 (en) | 2022-11-08 |
| AU2017287968A1 (en) | 2019-01-03 |
| FI3474913T3 (fi) | 2024-07-29 |
| KR102456201B1 (ko) | 2022-10-19 |
| AU2017287968B2 (en) | 2022-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11730866B2 (en) | Continuous-fiber reinforced biocomposite medical implants | |
| AU2017287968B2 (en) | Fiber reinforced biocomposite medical implants with high mineral content | |
| AU2018327272B2 (en) | Fiber reinforced biocomposite threaded implants | |
| JP7307960B2 (ja) | 繊維束補強生体複合医療用インプラント |